The Lancet. Infectious Diseases
-
Publication Venue For
- Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial. 22:622-635. 2022
- Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial 2022
- Nurses at the frontline of public health emergency preparedness and response: lessons learned from the HIV/AIDS pandemic and emerging infectious disease outbreaks.. 21:e326-e333. 2021
- Cryptococcal meningoencephalitis: time for action.. 21:e259-e271. 2021
- Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016.. 18:1229-1240. 2018
- Community-based intervention to increase HIV testing and case detection in people aged 16-32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study.. 11:525-532. 2011
- First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: An open-label, randomised phase 2/3 trial. 11:273-283. 2011
- Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings.. 8:516-523. 2008
- Immune reconstitution syndrome associated with opportunistic mycoses.. 7:395-401. 2007
- Hyperlactataemia syndromes associated with HIV therapy.. 3:329-337. 2003